1. Home
  2. GLDG vs CRVS Comparison

GLDG vs CRVS Comparison

Compare GLDG & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoldMining Inc.

GLDG

GoldMining Inc.

HOLD

Current Price

$1.38

Market Cap

279.0M

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$7.73

Market Cap

634.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDG
CRVS
Founded
2009
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.0M
634.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
GLDG
CRVS
Price
$1.38
$7.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.50
$13.75
AVG Volume (30 Days)
2.2M
1.6M
Earning Date
10-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$2.54
52 Week High
$1.80
$9.60

Technical Indicators

Market Signals
Indicator
GLDG
CRVS
Relative Strength Index (RSI) 51.86 44.45
Support Level $1.32 $7.34
Resistance Level $1.41 $8.00
Average True Range (ATR) 0.08 0.52
MACD 0.00 -0.12
Stochastic Oscillator 54.35 18.42

Price Performance

Historical Comparison
GLDG
CRVS

About GLDG GoldMining Inc.

GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: